Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04511637
Status:
COMPLETED
Last Update Posted:
2020-08-13
First Post:
2020-08-12
Brief Title:
Study to Compare the Effect of the Formulations Orally Disintegrating Tablet and Film-coated Tablet on the Bioequivalence of Drug Rivaroxaban Xarelto at Dose of 15 mg in Japanese Healthy Male Adult Subjects
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
20088
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen Research Development LLC | INDUSTRY |